Finance

Lists
Why is CLBIO up 2,92%?
Dive Deeper
CLBIO:STO
Corline Biomedical AB
14,10 SEK
+2,92%
(+0,40) 1D
13-окт., 17:29:41 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for CLBIO...
Open
14,10 SEK
High
14,10 SEK
Low
13,30 SEK
Mkt. cap
368,48 млн
Avg. vol.
9,14 миң
Volume
12,54 миң
52-wk high
22,30 SEK
52-wk low
13,15 SEK
EPS
-0,49 SEK
Shares outstanding
26,13 млн
No. of employees
14
Open
14,10 SEK
High
14,10 SEK
Low
13,30 SEK
Mkt. cap
368,48 млн
Avg. vol.
9,14 миң
Volume
12,54 миң
52-wk high
22,30 SEK
52-wk low
13,15 SEK
EPS
-0,49 SEK
Shares outstanding
26,13 млн
No. of employees
14
News stories
From web sources and news partners
About Corline Biomedical AB
CEOHenrik Nittmar
Employees14
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitecorline.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,30 млн
2,10 млн
4,29 млн
4,69 млн
Cost of goods sold
631,00 миң
716,00 миң
-79,00 миң
139,00 миң
Cost of revenue
631,00 миң
716,00 миң
-79,00 миң
139,00 миң
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,07 млн
6,47 млн
6,79 млн
6,00 млн
Operating expense
4,04 млн
6,46 млн
6,87 млн
6,02 млн
Total operating expenses
4,67 млн
7,17 млн
6,80 млн
6,16 млн
Operating income
-3,37 млн
-5,07 млн
-2,50 млн
-1,48 млн
Other non operating income
9,00 миң
-30,00 миң
2,00 миң
45,00 миң
EBT including unusual items
-3,36 млн
-5,03 млн
-2,50 млн
-1,44 млн
EBT excluding unusual items
-3,36 млн
-5,03 млн
-2,50 млн
-1,44 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-44,00 миң
-30,00 миң
61,00 миң
-15,00 миң
Net income
-3,36 млн
-5,03 млн
-2,50 млн
-1,44 млн
Net profit margin
-257,39%
-238,93%
-58,28%
-30,62%
Earnings per share
-
-
-
-
Interest and investment income
1,00 миң
38,00 миң
1,00 миң
-
Interest expense
-1,00 миң
-
-
-4,00 миң
Net interest expenses
-
38,00 миң
1,00 миң
-4,00 миң
Depreciation and amortization charges
12,00 миң
20,00 миң
20,00 миң
36,00 миң
EBITDA
-3,36 млн
-5,03 млн
-2,48 млн
-1,44 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору